CN1272055C - Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method - Google Patents
Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method Download PDFInfo
- Publication number
- CN1272055C CN1272055C CNB2003101032162A CN200310103216A CN1272055C CN 1272055 C CN1272055 C CN 1272055C CN B2003101032162 A CNB2003101032162 A CN B2003101032162A CN 200310103216 A CN200310103216 A CN 200310103216A CN 1272055 C CN1272055 C CN 1272055C
- Authority
- CN
- China
- Prior art keywords
- age
- preparation
- changchun
- chinese medicine
- testis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 210000003734 kidney Anatomy 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title claims description 53
- 239000002398 materia medica Substances 0.000 title 1
- 210000001550 testis Anatomy 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 27
- 210000003899 penis Anatomy 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241001550206 Colla Species 0.000 claims description 10
- 241000238040 Panulirus Species 0.000 claims description 10
- 241000927735 Penaeus Species 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 210000001320 hippocampus Anatomy 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 6
- 230000008093 supporting effect Effects 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 210000003056 antler Anatomy 0.000 abstract description 4
- 210000003414 extremity Anatomy 0.000 abstract description 4
- 201000001881 impotence Diseases 0.000 abstract description 4
- 206010036596 premature ejaculation Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 238000005728 strengthening Methods 0.000 abstract 2
- HVBGZKVTJLINJW-UHFFFAOYSA-N 3,4-dihydroxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products OC1C(O)(C(=O)OC)C2N(C)C3=CC=CC=C3C22CCN3CC=CC1(CC)C23 HVBGZKVTJLINJW-UHFFFAOYSA-N 0.000 abstract 1
- 241000143060 Americamysis bahia Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000003363 Cornus mas Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 241001505523 Gekko gecko Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241001247203 Syngnathidae Species 0.000 abstract 1
- 208000031975 Yang Deficiency Diseases 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 210000003127 knee Anatomy 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 40
- 239000002674 ointment Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 20
- 241000700159 Rattus Species 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000008187 granular material Substances 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 230000027326 copulation Effects 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 231100000682 maximum tolerated dose Toxicity 0.000 description 6
- 239000006187 pill Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000020374 simple syrup Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229960001712 testosterone propionate Drugs 0.000 description 4
- 208000019914 Mental Fatigue Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- -1 drying Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000004490 capsule suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a catharosine traditional Chinese medicine preparation for nourishing kidneys, strengthening yang and prolonging life and a preparation method, which relates to a traditional Chinese medicine preparation with the functions of kidney nourishing, yang strengthening, anti-exhaustion, anti-aging effect and immune function increase for human bodies and a preparation method thereof. The traditional Chinese medicine preparation is prepared by the following raw materials according to a weight percent: 0.5 to 10% of antlers, 0.1 to 3% of penis cervi, 0.3 to 5% of dog testes and penises, 3 to 20% of pig testes, 2 to 30% of big dried shrimps, 3 to 20% of dog bones, 3 to 20% of sea horses, 0.1 to 3% of tokay geckos, 1 to 15% of prepared rehmannia roots, 1 to 15% of tortoise-shell glue, 3 to 30% of solomonseal rhizomes, 5 to 30% of prepared fleeceflower roots, 3 to 30% of asiatic cornelian cherry fruit, 1 to 15% of ginseng, 2 to 20% of common cnidium fruit, 1 to 15% of epimedium herbs and 1 to 15% of stalactite. The traditional Chinese medicine preparation can comprehensively treat the symptoms, such as kidney and yang deficiency, essence and blood deficiency, waist and knee soreness and pain, limb coldness, physical exhaustion and weakness, sexual impotence, premature ejaculation, premature graying hair, spiritual exhaustion, thinness, etc. and has the advantages of high cure rate and obvious curative effects.
Description
Technical field
The present invention relates to a kind of can kidney invigorating and YANG supporting, resisting fatigue, defying age, increase body immune function to be to reach Chinese medicine preparation that prolongs Changchun purpose in age and preparation method thereof.
Background technology
Quickening along with modern life rhythm, hypertonicity, overtired, the over-drastic life of physical demands, made people show the obvious deficiency of muscle power, the consequence of long-run development is to cause the human body functional disorder, and thanks to void, soreness of waist and knee joint, extremity cold, fatigue and asthenia, impotence and premature ejaculation, early whitening of beard and hair, Mental fatigue are won symptoms such as thin to show as insufficiency of kidney-YANG, essence and blood.People are for building body, have to take in a large number various health products, costing an arm and a leg of health product, the effective ingredient of its treatment disease is very limited, it is effective in cure to need to take in a large number for a long time, and its marketing management is also extremely lack of standardization, and the treatment that is difficult to suit the remedy to the case is basic, extremely uneconomical, not the effective way of people's normal therapeutic disease.Can effectively treat the Chinese medicine of these symptom diseases in the market, its cure rate is low, and curative effect is not obvious.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind of kidney invigorating and YANG supporting and prolong Changchun Chinese medicine preparation and preparation method in age, this Chinese medicine preparation can effectively be regulated the function of human body, can kidney invigorating and YANG supporting, resisting fatigue, defying age, increase body immunity, benefiting essence and marrow, helping inspiration to relieve asthma can the Comprehensive Treatment insufficiency of kidney-YANG, and essence and blood loses empty, soreness of waist and knee joint, extremity cold, fatigue and asthenia, impotence and premature ejaculation, early whitening of beard and hair, Mental fatigue is won thin grade for disease, its cure rate height, and curative effect is obvious.
The invention provides following technical scheme: a kind of kidney invigorating and YANG supporting prolongs Changchun Chinese medicine preparation in age, it is characterized in that: about preparation is formulated by following raw materials according percentage ratio by weight in this: Cornu Cervi Pantotrichum 0.5-10%, Penis et testis cervi 0.1-3%, Penis et testis canitis 0.3-5%, pig testis 3-20%, Penaeus seu panulirus 2-30%, Os Canitis 3-20%, hippocampus 3-20%, Gecko 0.1-3%, Radix Rehmanniae Preparata 1-15%, Colla Plastri Testudinis 1-15%, Rhizoma Polygonati 3-30%, Radix Polygoni Multiflori Preparata 5-30%, Fructus Corni 3-30%, Radix Ginseng 1-15%, Fructus Cnidii 2-20%, Herba Epimedii 1-15% and Stalactitum 1-15%.
Described raw material is by formulated by the percentage ratio of following weight: Cornu Cervi Pantotrichum 1.36%, Penis et testis cervi 0.39%, Penis et testis canitis 0.78%, pig testis 8.00%, Penaeus seu panulirus 6.55%, Os Canitis 9.36%, Hippocampus 8.32%, Gecko 0.31%, Radix Rehmanniae Preparata 4.79%, Colla Plastri Testudinis 4.68%, Rhizoma Polygonati 9.67%, Radix Polygoni Multiflori Preparata 14.36%, Fructus Corni 9.36%, Radix Ginseng 3.12%, Fructus Cnidii 7.29%, Herba Epimedii 4.79% and Stalactitum 6.87%.
Described Chinese medicine preparation is into tablet, capsule, granule, powder, pill, oral liquid or syrup.
The preparation method of described tablet, undertaken by following process: (1) is got Radix Rehmanniae Preparata, Os Canitis, Fructus Cnidii, Fructus Corni and Herba Epimedii and is ground into thick piece, add above 3-8 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filtered, merging filtrate, be concentrated into paste, the relative density in the time of its 50 ℃ is 1.0-1.5; (2) get Cornu Cervi Pantotrichum, Colla Plastri Testudinis, Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Polygonati and Stalactitum and be ground into 60-120 purpose fine powder; (3) getting Penis et testis canitis, Penis et testis cervi, pig testis, Gecko, Penaeus seu panulirus and Hippocampus adds above each component gross weight 3-8 doubly to measure concentration is 30-60% ethanol, heating and refluxing extraction 1-3 time, each 3-7 hour, gradation filters, merging filtrate, reclaim ethanol and be concentrated into paste, the relative density in the time of its 50 ℃ is 1.0-1.5; (4) medicated powder that makes of the ointment that (1) method is made, (2) method mixes with the ointment that (3) method makes, and 60-100 ℃ of drying pulverized, sieve, add starch or dextrin and other adjuvant and make granule, drying, granulate adds the compacting of magnesium stearate or other adjuvant in flakes.
The preparation method of described capsule, undertaken by following process: get the ointment that (1) method makes in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized, and sieves, and incapsulates to get final product.
The preparation method of described granule, undertaken by following process: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized, sieve, add starch or dextrin and other adjuvant and make granule.
The preparation method of described powder, undertaken by following process: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized and got final product.
The preparation method of described pill, undertaken by following process: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying is ground into powder; The Mel of the grain weight of getting it filled amount 80-130% boils, and filters; Behind medicated powder, 80-130% Mel and 0-15% water mix homogeneously, make pill.
The preparation method of described oral liquid, undertaken by following process: (1) is got Radix Rehmanniae Preparata, Os Canitis, Fructus Cnidii, Fructus Corni, Herba Epimedii, Stalactitum and Colla Plastri Testudinis and is ground into thick piece, add above 3-8 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, and merging filtrate concentrates; (2) getting Penis et testis canitis, Penis et testis cervi, pig testis, Gecko, Penaeus seu panulirus, Hippocampus, Cornu Cervi Pantotrichum, Radix Ginseng, Radix Polygoni Multiflori and Rhizoma Polygonati adds above each component gross weight 3-8 doubly to measure concentration is 30-90% ethanol, heating and refluxing extraction 1-3 time, each 3-7 hour, gradation filtered, merging filtrate concentrates; (3) concentrated medicament that a method, b method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
The preparation method of described syrup, undertaken by following process: (1) will merge by the concentrated medicament that above-mentioned oral liquid preparation technology (1), (2) make, and filters; (2) sucrose is dissolved in the distilled water that boils, making concentration is the simple syrup of 85% (g/ml) or 64.7% (g/g); (3) will filter the back medicinal liquid and add in the simple syrup, and add an amount of distilled water and make syrup.
This Chinese medicine preparation has carried out a large amount of clinical trials of a large amount of animal acute toxicity tests, long-term toxicity test for animals, animal pharmacodynamics test and treatment disease, and the use link of this medicine input being treated disease provides science and objective foundation.Its test method and result of the test are as follows respectively:
1, prolong Changchun capsule animal acute toxicity test in age:
Medicine: prolong Changchun capsule in age, provide lot number by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province: 980301.
Experimental animal: Kunming mouse, body weight 18-20g, male and female half and half are provided by Norman Bethune Medical University animal portion experimental center, the quality certification number: 98050103.
Method and result: give the concentration (40%) of Kunming mouse with maximum through trial test, it is dead that maximum volume, 40ml/kg once gavage none example, do not measure LD
50So, carry out maximum tolerated dose (MTD) and measure.
Get 20 of kunming mices, male and female half and half, the record body weight, water is can't help in fasting, once gavages in one day to prolong Changchun capsule suspension 16g/kg in age, and normal breeding observing is 7 days after the mice administration, and do not see animal dead and the overt toxicity reaction occurs,
Maximum tolerated dose MTD=40g/ml * 40ml/kg * 1=16g/kg
Adult (60kg) dose=0.3g every day * 6 * 3 times=5.4g
{ adult (60g) dose/60}=16/ every day (5.4/60)=178 times of MTD ÷
Conclusion: prolong age Changchun capsule to the acute toxicity test of mice, do not measure LD
50, the maximum tolerated dose of its gastric infusion is 16g/kg, is equivalent to 178 times of clinical application, as seen this poison of drug is little, is a kind of than safe drugs.
2, prolong Changchun capsule long-term toxicity test for animals in age:
Medicine: prolong Changchun capsule in age, provide lot number by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province: 980301.
Experimental animal: the SD rat, body weight 148-169g, male and female half and half, portion provides by the Norman Bethune Medical University animal, the quality certification number: 98051010.
Grouping and dosage:
Rat elder generation sub-cage rearing, adapted to for two weeks after, be divided into 1 at random by sex) matched group: irritate stomach with tap water 2.0ml/100g every day; 2) prolong Changchun capsule low dose group in age: irritate stomach with 1.8g/kg; 3) prolong Changchun capsule in high dose group in age: irritate stomach with 4.5g/kg.
Begin gastric infusion after adapting to for 2 weeks earlier before the experiment, by above dosage 8 o'clock every mornings administration.
Conclusion: two groups of rats are taken continuously and prolong Changchun capsule 4.5g/kg in age, 1.8g/kg (be equivalent to 50 times of human dosage, 20 times) after 60 days, body weight gain, hematology, blood biochemical are learned index and main organs and matched group and relatively be there is no significant difference, explanation under above-mentioned dosage, prolong age the Changchun capsule to take February continuously be safe.
3, animal pharmacodynamics test
Test objective: observe by animal experiment and to prolong age Changchun capsule to the influence of sexual function, defying age and human body adaptive capacity, for its clinical practice provides the pharmacodynamics test foundation.
Trial drug: prolong Changchun capsule in age, lot number is provided by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province: 980301, Hui Erchun China Sang Hai pharmaceutical factory produces lot number: 970516.The flavone injection, Shanghai the 9th pharmaceutical factory's product, lot number: 970517-2, testosterone propionate injection, Mingguang City, Guangzhou pharmaceutical factory product, lot number: 960605-2.
Test apparatus: instrument is used in the practicality of YSD-5 type pharmacology physiology more, Bengbu Medical College's radio two factory's products.
Experimental animal: SD is tied to form a year rat, body weight 220-280g, and the quality certification number: 98051010, Kunming mouse, the quality certification number: 98050103, portion provides by the Norman Bethune Medical University animal.
Test method:
1) prolongs age Changchun capsule to the influence of sexual function of rats
A) prolong age Changchun capsule to the influence of rat mating test
Get 40 of male rats, body weight 220-280g is divided into 4 groups, matched group (distilled water 10ml/kg/d), prolong Changchun capsule high and low dose group in age (0.36g/kg/d, 0.18g/kg/d), Hui Erchun (6.67ml/kg/d), above-mentioned ig administration every day 1 time, the 15d continuously of respectively organizing.
Female Mus is prepared: get 40 of female Mus, pentobarbital sodium 40mg/kg, intraperitoneal anesthesia, implement the bilateral ovaries enucleation, postoperative intramuscular injection penicillin 100,000 a u/ x3d, operation two all backs and male copulation, preceding 48hsc. estradiol benzoate 20ug/ of copulation, 4hsc. Progesterone 0.5mg/ only before the copulation.
Earlier male Mus is put into 60cm * 40cm * 25cm wire mesh cage 5min, make its every cage that conforms then put into 10 female Mus, mate the back and continue to male Mus perfusion every day, continue a week, write down the average number of copulations of each treated animal.As table 1.
Group dosage (g/kg) number of copulations table 1
Matched group-13.1 ± 4.3
Prolong Changchun capsule low dose group 0.18 23.5 ± 6.2* in age
Prolong Changchun capsule in high dose group 0.36 36.8 ± 5.9** in age
Hui Erchun group 6.67g/mg 31.7 ± 6.9*
Compare with matched group
*P＜0.05
*P＜0.01
Result of the test shows: prolong Changchun capsule high and low dose group in age (0.36g/kg, 0.18g/kg are equivalent to 4 times of clinical consumption, 2 times respectively), can significantly improve the number of copulations of rat, with matched group tangible statistical significance (P＜0.05) is arranged relatively.
B) prolong age Changchun capsule to the effect of castration male rat erection:
Get 40 of male rats, body weight 220-280g, pentobarbital sodium intraperitoneal injection of anesthesia (40mg/kg), extract bilateral testes, postoperative intramuscular injection penicillin (100,000 a u/ x3d), castration operation back 3d is divided into rat 4 groups: castration model group (distilled water 10ml/kg/d) at random; Prolong Changchun capsule high and low dose group in age (0.36g/kg/d, 0.18g/kg/d); Testosterone propionate injection group (2mg/kg/d), other annotates normal control group (not castration, distilled water 10ml/kg/d), and except that the testosterone propionate injection group was the SC. administration, all the other each groups were the ig administration, every day 1 time, 20d continuously.
How 1h after the last administration prevents YSD-5 type pharmacology, physiology to give 4mA galvanism near skin rat penis head and the urethral orifice with the stimulating electrode of instrument, and record begins to the incubation period of penis erection from stimulation.See Table 2.
Group dosage (g/kg) erection table 2 incubation period
Normal control group-14.83 ± 3.51
Castration model group-22.73 ± 4.17**
Prolong Changchun capsule low dose group 0.18 15.64 ± 3.98## in age
Prolong Changchun capsule in high dose group 0.36 14.35 ± 3.47## in age
Testosterone propionate injection group 2g/kg 12.58 ± 3.15##
Compare with the normal control group
*P＜0.01; Compare ##P＜0.01 with the castration model group
Result of the test shows: prolong age Changchun capsule high and low dose and can improve the male Mus erection of castration ability, shorten the incubation period of electric stimulus inducing erection, with the castration matched group obvious statistical significance P＜0.01 is arranged relatively.
2) prolong the capsular anti-aging effects in Changchun in age
A) prolong age Changchun capsule to the effect of D-galactose induced mice aging model:
Get 50 of mices, the male and female dual-purpose, body weight 28-30g is divided into 4 groups at random, be normal control group (normal saline 10ml/kg/d), model control group (normal saline 10ml/kg/d) is prolonged Changchun capsule high and low dose group (0.9g/kg/d, 0.45g/kg/d in age, be equivalent to 5 times of clinical consumption respectively, 10 times), Hui Erchun organizes (6.67ml/kg/d), by above dosage ig every day administration 1 time; 2-5 organizes every Mus iPD-galactose 120mg/kg simultaneously, capacity normal saline such as normal control group ip in mice, continuous 25d, 24h after the last administration wins the eyeball blood sampling, survey superoxide dismutase (SOD) and hemoglobin (Hb), and put to death animal, and get liver, brain immediately, make 10% liver homogenate with phosphate buffer respectively, brain homogenate is surveyed lipid peroxide (LPO) and protein (P); Accurately take by weighing heart 0.1g in addition, brain 0.1g makes homogenate respectively, surveys lipofuscin (LF) content.Record is as table 3 respectively.Table 3
The group dosage SOD property controlled (U/mg.Hb) LPO content (nmol/mg.Pr) LF content (u/g)
(g/kg) the blood liver liver brain brain heart
Normal control group-53.8 ± 14.7 3.3 ± 0.6 102.3 ± 41.4 76.1 ± 30.8 34.7 ± 6.8 43.4 ± 6.3
Model control group-39.8 ± 9.2*, 2.7 ± 0.6*, 144.3 ± 47.5*, 118.5 ± 23.1*, 43.2 ± 9.6*, 50.5 ± 5.5*
Prolong Changchun Capsules group 0.45 53.7 ± 6.6# 4.0 ± 0.9## 89.5 ± 26.2## 71.0 ± 225# 28.2 ± 5.1# 32.6 ± 6.4# in age
Prolong Changchun Capsules group 0.90 58.5 ± 11.8# 4.1 ± 1.2## 78.9 ± 23.6## 53.4 ± 26.1## 11.7 ± 2.4## 7.2 ± 2.6## in age
Favour face spring group 6.67ml/kg 63.9 ± 7.0# 3.8 ± 0.8## 97.1 ± 30.8# 65.1 ± 16.2# 13.4 ± 2.8## 7.9 ± 1.8##
Compare with matched group:
*P＜0.05; Compare with model control group: #P＜0.05 ##P＜0.01
The result shows: prolong Changchun capsule high and low dose group (0.9g/kg/d in age, 0.45g/kg/d, be equivalent to 10 times of clinical consumption respectively, 5 times) can make that mouse aging SOD is active due to the D-galactose raises, LPO generates and reduces and the reduction of LF content, compared tangible statistical significance with matched group, (P＜0.01 or P＜0.05).
B) to the influence of mice carbon clearance effect
Get 40 of mices, the male and female dual-purpose, body weight 16-19g is divided into 4 groups, by above-mentioned defying age test dose 1 continuous 7d every day, last administration 20min, every Mus iv20% india ink 0.1ml/10g injection back 2min and 20min is respectively got blood 20ul by the eyes vein respectively, is dissolved in the 2ml0.1% sodium bicarbonate solution, uses the 721 type spectrophotometers (colorimetric of λ=650nm) then, the absorption value of test sample product, and calculate and clean up index.See Table 4.
Group dosage (g/kg) erection table 4 incubation period
Normal control group-0.012 ± 0.008
Prolong Changchun capsule low dose group 0.45 0.024 ± 0.007** in age
Prolong Changchun capsule in high dose group 0.90 0.028 ± 0.008** in age
Hui Erchun group 6.67ml/kg 0.024 ± 0.010**
Compare with matched group
*P＜0.01
Result of the test shows: prolong Changchun high and low dose group (0.9g/kg/d in age, 0.45g/kg/d, be equivalent to 10 times of clinical consumption respectively, 5 times) can increase carbon clearance index in the mice body, improve the huge phagocytic function of biting system of monokaryon, tangible statistical significance (P＜0.01) is relatively arranged with matched group.
3) prolong the capsular antifatigue effect in Changchun in age
Get 40 of mices, the male and female dual-purpose, body weight 18-22g is divided into 4 groups at random, press table 5 dosage administration every day 1 time, continuous 3d, 40min after the last administration presses body weight 5% at the afterbody application of load with mice respectively, put into depth of water 25cm, in the bucket that water temperature is 21 ℃, begin swimming, and the recording start swimming whole swimming time till be drowned.As following table 5.
Group dosage (g/kg) swimming time prolongs counting rate meter 5
Normal control group-8.8 ± 3
Prolong Changchun capsule low dose group 0.45 15.2 ± 7.5* 76.0 in age
Prolong Changchun capsule in high dose group 0.90 33.8 ± 27.1** 293.0 in age
Hui Erchun group 6.67ml/kg 12.9 ± 5.9* 50.0
Compare with matched group
*P＜0.05,
*P＜0.01
Result of the test shows: prolong Changchun high and low dose group (0.9g/kg/d in age, 0.45g/kg/d, be equivalent to 10 times of clinical consumption respectively, 5 times) and can obviously prolong the mice swimming time, relatively compare with matched group, have tangible statistical significance (P＜0.05 or P＜0.01 〉.
In order to verify clinical efficacy, this prolongs age Changchun capsule and has passed through the clinical observation of 120 examples, and prolongs the age sheet with 60 routine ginseng and pilose antlers and carry out controlled observation, and the treatment group is thrown and prolonged Changchun capsule in age, and each 4-6 grain is every day 2-3 time, oral.Matched group is thrown ginseng and pilose antler and prolonged each 3 of sheet in age (Dongfeng Pharmaceutical Factory), and is oral every day 3 times, and one month is a course of treatment, and other medicines relevant with treatment of stopping using during the treatment carry out comprehensive review after finishing the course of treatment, and its result is adopted t check, x
2Statistical procedures is carried out in check.Total effects sees Table 6.
Group recovery from illness produce effects enabledisable effective percentage (%) table 6
Treatment organizes 1 53 55 11 90.8
Matched group 0 22 25 13 78.3
u＝3.68 P＜0.01
By table as seen, treatment group total effective rate is 90.8%, matched group total effective rate 78.3%, credit is analysed and is prolonged age Changchun capsule curative effect and prolong sheet P in age＜0.01 apparently higher than ginseng and pilose antler by statistics, cardinal symptom after treatment is obviously improved, illustrate that prolonging age Changchun capsule shows as essence and blood to the insufficiency of kidney-YANG person and lose empty, soreness of waist and knee joint, extremity cold, fatigue and asthenia, impotence and premature ejaculation, early whitening of beard and hair, the Mental fatigue win is thin to wait disease that good curative effect is arranged, its curative effect and age, the course of disease does not have tangible dependency, treatment junior scholar routine, routine urinalysis, electrocardiogram, inspection indexs such as liver function change with treat before the no significant difference of comparing, have no adverse reaction, have no side effect.
Beneficial effect of the present invention: show that through above result of the test this prolongs age Changchun capsule for treating insufficiency of kidney-YANG syndrome tangible curative effect, its cure rate height has no side effect, and has promotional value widely.
The specific embodiment
A kind of kidney invigorating and YANG supporting prolongs Changchun Chinese medicine preparation in age, is tablet, capsule, granule, powder, pill, oral liquid or syrup.
The preparation of raw material that its Chinese medicine preparation is pressed column weight amount percentage ratio forms: Cornu Cervi Pantotrichum 0.5-10%, Penis et testis cervi 0.1-3%, Penis et testis canitis 0.3-5%, pig testis 3-20%, Penaeus seu panulirus 2-30%, Os Canitis 3-20%, hippocampus 3-20%, Gecko 0.1-3%, Radix Rehmanniae Preparata 1-15%, Colla Plastri Testudinis 1-15%, Rhizoma Polygonati 3-30%, Radix Polygoni Multiflori Preparata 5-30%, Fructus Corni 3-30%, Radix Ginseng 1-15%, Fructus Cnidii 2-20%, Herba Epimedii 1-15% and Stalactitum 1-15%.
Its best proportioning is: Cornu Cervi Pantotrichum 1.36%, Penis et testis cervi 0.39%, Penis et testis canitis 0.78%, pig testis 8.00%, Penaeus seu panulirus 6.55%, Os Canitis 9.36%, Hippocampus 8.32%, Gecko 0.31%, Radix Rehmanniae Preparata 4.79%, Colla Plastri Testudinis 4.68%, Rhizoma Polygonati 9.67%, Radix Polygoni Multiflori Preparata 14.36%, Fructus Corni 9.36%, Radix Ginseng 3.12%, Fructus Cnidii 7.29%, Herba Epimedii 4.79% and Stalactitum 6.87%.
Its weight can take by weighing like this: Cornu Cervi Pantotrichum 1.36g, Penis et testis cervi 0.39g, Penis et testis canitis 0.78g, pig testis 8.00g, Penaeus seu panulirus 6.55g, Os Canitis 9.36g, Hippocampus 8.32g, Gecko 0.31g, Radix Rehmanniae Preparata 4.79g, Colla Plastri Testudinis 4.68g, Rhizoma Polygonati 9.67g, Radix Polygoni Multiflori Preparata 14.36g, Fructus Corni 9.36g, Radix Ginseng 3.12g, Fructus Cnidii 7.29g, Herba Epimedii 4.79g, Stalactitum 6.87g.
Its tablet is made like this: (1) takes by weighing Radix Rehmanniae Preparata, Os Canitis, Fructus Cnidii, Fructus Corni and Herba Epimedii and is ground into thick piece by above weight, add above 3-8 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, merging filtrate is concentrated into paste, and the relative density in the time of its 50 ℃ is 1.0-1.5; (2) take by weighing Cornu Cervi Pantotrichum, Colla Plastri Testudinis, Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Polygonati and Stalactitum and be ground into 60-120 purpose fine powder by above weight; (3) taking by weighing Penis et testis canitis, Penis et testis cervi, pig testis, Gecko, Penaeus seu panulirus and Hippocampus by above weight adds above each component gross weight 3-8 doubly to measure concentration is 30-60% ethanol, heating and refluxing extraction 1-3 time, each 3-7 hour, gradation filters, merging filtrate, reclaim ethanol and be concentrated into paste, the relative density in the time of its 50 ℃ is 1.0-1-5; (4) medicated powder that makes of the ointment that (1) method is made, (2) method mixes with the ointment that (3) method makes, and 60-100 ℃ of drying pulverized, sieve, add starch or dextrin and other adjuvant and make granule, drying, granulate adds the compacting of magnesium stearate or other adjuvant in flakes.
Its capsule is made like this: get the ointment that (1) method makes in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized, and sieves, and incapsulates to get final product.
Its granule is made like this: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized, and sieves, and adds starch or dextrin and other adjuvant and makes granule.
Its powder is made like this: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying pulverized and got final product.
Its pill is made like this: get the ointment of (1) method in the above-mentioned method for preparing tablet thereof, the medicated powder that (2) method makes mixes with the ointment that (3) method makes, 60-100 ℃ of drying is ground into powder; The Mel of the grain weight of getting it filled amount 80-130% boils, and filters; Behind medicated powder, 80-130% Mel and 0-15% water mix homogeneously, make pill.
Its oral liquid is made like this: (1) is got Radix Rehmanniae Preparata, Os Canitis, Fructus Cnidii, Fructus Corni, Herba Epimedii, Stalactitum and Colla Plastri Testudinis and is ground into thick piece, adds above 3-8 times of water gaging of each component gross weight, and heating decocts 1-3 time, each 1-4 hour, gradation filters, and merging filtrate concentrates; (2) getting Penis et testis canitis, Penis et testis cervi, pig testis, Gecko, Penaeus seu panulirus, Hippocampus, Cornu Cervi Pantotrichum, Radix Ginseng, Radix Polygoni Multiflori and Rhizoma Polygonati adds above each component gross weight 3-8 doubly to measure concentration is 30-90% ethanol, heating and refluxing extraction 1-3 time, each 3-7 hour, gradation filtered, merging filtrate concentrates; (3) concentrated medicament that a method, b method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
Its syrup is made like this: (1) will merge by the concentrated medicament that above-mentioned oral liquid preparation technology (1), (2) make, and filters; (2) sucrose is dissolved in the distilled water that boils, making concentration is the simple syrup of 85% (g/ml) or 64.7% (g/g); (3) will filter the back medicinal liquid and add in the simple syrup, and add an amount of distilled water and make syrup.
Claims (1)
1, a kind of kidney invigorating and YANG supporting prolongs the preparation method of Changchun Chinese medicine preparation in age, it is characterized in that it carries out according to the following steps: (1) is got Radix Rehmanniae Preparata 4.79%, Os Canitis 9.36%, Fructus Cnidii 7.29%, Fructus Corni 9.36%, Herba Epimedii 4.79%, Stalactitum 6.87% and Colla Plastri Testudinis 4.68% and is ground into thick piece, add above 3-8 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, and merging filtrate concentrates; (2) getting Penis et testis canitis 0.78%, Penis et testis cervi 0.39%, pig testis 8.00%, Gecko 0.31%, Penaeus seu panulirus 6.55%, Hippocampus 8.32%, Cornu Cervi Pantotrichum 1.36%, Radix Ginseng 3.12%, Radix Polygoni Multiflori 14.36% and Rhizoma Polygonati 9.67% adds above each component gross weight 3-8 doubly to measure concentration is 30-90% ethanol, heating and refluxing extraction 1-3 time, each 3-7 hour, gradation filters, merging filtrate concentrates; (3) concentrated medicament that a method, b method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101032162A CN1272055C (en) | 2003-10-30 | 2003-10-30 | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101032162A CN1272055C (en) | 2003-10-30 | 2003-10-30 | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1539460A CN1539460A (en) | 2004-10-27 |
| CN1272055C true CN1272055C (en) | 2006-08-30 |
Family
ID=34333244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101032162A Expired - Fee Related CN1272055C (en) | 2003-10-30 | 2003-10-30 | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1272055C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101912487B (en) * | 2010-08-03 | 2012-11-21 | 彭树林 | Medicament for treating neuroendocrine disturbance, sexual function decline and skin aging |
| CN102614441B (en) * | 2011-01-26 | 2014-04-30 | 广州万正药业有限公司 | Medicinal composition and preparation method thereof |
| CN102274263B (en) * | 2011-09-08 | 2014-08-06 | 珲春华瑞参业生物工程有限公司 | Transplanted panax ginseng plant-pilos antler-deer penis capsules and preparation method thereof |
| CN104940234A (en) * | 2015-06-01 | 2015-09-30 | 江西省牧蕾农林开发有限公司 | Health product for improving immunity, building body and enhancing male sexual function |
| CN106421334A (en) * | 2015-08-21 | 2017-02-22 | 牟之梨 | Chinese medicine prescription for excessive sexual intercourse caused impotence |
| CN106177317A (en) * | 2016-07-29 | 2016-12-07 | 中国农业科学院特产研究所 | A kind of warming the kidney to invigorate YANG, the instant Cornu Cervi Pantotrichum sheet and preparation method thereof of strengthening the tendons and bones |
| CN108294307A (en) * | 2018-01-17 | 2018-07-20 | 上海茂久中医药科技有限公司 | A kind of nutriment containing testis Gallus domesticu, cockscomb, Herba Epimedii |
| CN109259219A (en) * | 2018-10-24 | 2019-01-25 | 吉林海王健康生物科技有限公司 | A kind of deer whip honeyed bolus and preparation method thereof |
-
2003
- 2003-10-30 CN CNB2003101032162A patent/CN1272055C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1539460A (en) | 2004-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1245187C (en) | Medicine for treating eye disease caused by visceral disease | |
| CN1857690A (en) | Gynecopathy treating preparation and its preparing process | |
| CN101053621A (en) | Traditional Chinese medicinal composition for treating obesity and its preparation method | |
| CN1712054A (en) | Qinchuan Tongbi tablet | |
| CN1272055C (en) | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method | |
| CN1108804C (en) | Diabetes treating medicine and its prepn. method | |
| CN1679864A (en) | Chinese medicine preparation for treating bronchitis | |
| CN101049340A (en) | A pharmaceutical composition for treating vitiligo and its preparation method | |
| CN1742775A (en) | Medicine composition for preventing and treating orthopedic diseases | |
| CN101045137A (en) | Capsule for treating epilepsia and its preparing method | |
| CN1840160A (en) | Powder for resisting hyperosteogeny | |
| CN1048636C (en) | Special Chinese-medicinal preparation for radically dropping drug | |
| CN112494569B (en) | Traditional Chinese medicine composition for improving immunity and preparation method and application thereof | |
| CN1907335A (en) | Pharmaceutical composition for treating nasosinusitis and its preparing process | |
| CN1562116A (en) | Chinese medicine preparation with invigorating kidney function | |
| CN1250247C (en) | Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation | |
| CN104983759A (en) | Traditional Chinese medicine composition treating diabetic nephropathy and preparing method thereof | |
| CN1814163A (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
| CN1092968C (en) | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons | |
| CN103751692B (en) | Special invigorating capsule of a kind of Testis et penis callorhini and preparation method thereof | |
| CN1278734C (en) | Pharmaceutical composition for stopping drug addiction and its preparing process | |
| CN1259953C (en) | Anti aging health caring medicine | |
| CN101474277A (en) | Medicine composition for rheumatism and its preparation | |
| CN1785410A (en) | Preparation method of ready prepared chinese medicinal granules for treathing pains | |
| CN1857559A (en) | Impotence treating medicine and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20070618 Pledge (preservation): Preservation |
|
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20080618 Pledge (preservation): Preservation registration |
|
| ASS | Succession or assignment of patent right |
Owner name: LIAOYUAN YULONGYA PHARMACEUTICAL CO.LTD. Free format text: FORMER OWNER: LIAOYUAN YADONG MEDICINE CO., LTD., JILIN PROVINCE Effective date: 20080926 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080926 Address after: Jilin city of Liaoyuan province Yiyang Friendship Road No. 5 Patentee after: LIAOYUAN YULONGYADONG PHARMACEUTICAL Co.,Ltd. Address before: No. 33 Youyi Road, Jilin, Liaoyuan Patentee before: Jilin Liaoyuan Yadong Pharmaceutical Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060830 |